Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Bilsland

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Neoplasia (New York, N.Y.)|May 11, 2010
TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expressionKyle Lafferty-Whyte, Alan Bilsland, Stacey F Hoare, et al.
BMC Blood Disorders|June 24, 2004
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal HaemoglobinuriaW Nicol Keith, Tom Vulliamy, Jiangqin Zhao, et al.
BMC Genomics|October 6, 2010
Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in peritoneal mesotheliomaKyle Lafferty-Whyte, Alan Bilsland, Claire J Cairney, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 20, 2016
Investigating Various Thresholds as Immunohistochemistry Cutoffs for Observer AgreementAsif Ali, Sarah Bell, Alan Bilsland, et al.
Seminars in Cancer Biology|April 15, 2015
Therapeutic targeting of replicative immortalityPaul Yaswen, Karen L MacKenzie, W Nicol Keith, et al.
Seminars in Cancer Biology|January 21, 2015
Broad targeting of angiogenesis for cancer prevention and therapyZongwei Wang, Charlotta Dabrosin, Xin Yin, et al.
Seminars in Cancer Biology|March 31, 2015
Immune evasion in cancer: Mechanistic basis and therapeutic strategiesDass S Vinay, Elizabeth P Ryan, Graham Pawelec, et al.
Seminars in Cancer Biology|April 15, 2015
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutritionLynnette R Ferguson, Helen Chen, Andrew R Collins, et al.
Seminars in Cancer Biology|April 21, 2015
Sustained proliferation in cancer: Mechanisms and novel therapeutic targetsMark A Feitelson, Alla Arzumanyan, Rob J Kulathinal, et al.
Seminars in Cancer Biology|March 10, 2015
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compoundsA R M Ruhul Amin, Phillip A Karpowicz, Thomas E Carey, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Neoplasia (New York, N.Y.)|May 11, 2010
TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expressionKyle Lafferty-Whyte, Alan Bilsland, Stacey F Hoare, et al.
BMC Blood Disorders|June 24, 2004
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal HaemoglobinuriaW Nicol Keith, Tom Vulliamy, Jiangqin Zhao, et al.
BMC Genomics|October 6, 2010
Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in peritoneal mesotheliomaKyle Lafferty-Whyte, Alan Bilsland, Claire J Cairney, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 20, 2016
Investigating Various Thresholds as Immunohistochemistry Cutoffs for Observer AgreementAsif Ali, Sarah Bell, Alan Bilsland, et al.
Seminars in Cancer Biology|April 15, 2015
Therapeutic targeting of replicative immortalityPaul Yaswen, Karen L MacKenzie, W Nicol Keith, et al.
Seminars in Cancer Biology|January 21, 2015
Broad targeting of angiogenesis for cancer prevention and therapyZongwei Wang, Charlotta Dabrosin, Xin Yin, et al.
Seminars in Cancer Biology|March 31, 2015
Immune evasion in cancer: Mechanistic basis and therapeutic strategiesDass S Vinay, Elizabeth P Ryan, Graham Pawelec, et al.
Seminars in Cancer Biology|April 15, 2015
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutritionLynnette R Ferguson, Helen Chen, Andrew R Collins, et al.
Seminars in Cancer Biology|April 21, 2015
Sustained proliferation in cancer: Mechanisms and novel therapeutic targetsMark A Feitelson, Alla Arzumanyan, Rob J Kulathinal, et al.
Seminars in Cancer Biology|March 10, 2015
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compoundsA R M Ruhul Amin, Phillip A Karpowicz, Thomas E Carey, et al.
Pageof 3